Skip to content
10-Q

Quarterly Report

Raphael Pharmaceutical Inc. RAPH

0001213900-25-109968

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 13, 2025 19.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 19.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 19.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.65M sh
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$256K
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$470K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$1.26M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$1.05M
Stockholders Equity Q3 2025 · Mar 31, 2025 −$734K
Stockholders Equity Q3 2025 · Dec 31, 2024 −$742K
Stockholders Equity Q3 2025 · Sep 30, 2024 −$616K
Stockholders Equity Q3 2025 · Jun 30, 2024 −$290K
Stockholders Equity Q3 2025 · Mar 31, 2024 −$103K
Stockholders Equity Q3 2025 · Dec 31, 2023 $267K
Current Liabilities Q3 2025 · Sep 30, 2025 $1.27M
Current Liabilities Q3 2025 · Dec 31, 2024 $769K
Current Assets Q3 2025 · Sep 30, 2025 $5K
Current Assets Q3 2025 · Dec 31, 2024 $25K
Total Assets Q3 2025 · Sep 30, 2025 $7K
Total Assets Q3 2025 · Dec 31, 2024 $27K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.01
Eps Diluted Q3 2025 · Sep 30, 2025 $0.05
Eps Diluted Q3 2025 · Sep 30, 2024 $0.01
Eps Diluted Q3 2025 · Sep 30, 2024 $0.06
Eps Basic Q3 2025 · Sep 30, 2025 $0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.05
Eps Basic Q3 2025 · Sep 30, 2024 $0.01
Eps Basic Q3 2025 · Sep 30, 2024 $0.06
Sga Expense Q3 2025 · Sep 30, 2025 $178K
Sga Expense Q3 2025 · Sep 30, 2025 $705K
Sga Expense Q3 2025 · Sep 30, 2024 $157K
Sga Expense Q3 2025 · Sep 30, 2024 $550K
Rd Expense Q3 2025 · Sep 30, 2025 $73K
Rd Expense Q3 2025 · Sep 30, 2025 $286K
Rd Expense Q3 2025 · Sep 30, 2024 $162K
Rd Expense Q3 2025 · Sep 30, 2024 $565K
Net Income Q3 2025 · Sep 30, 2025 −$255K
Net Income Q3 2025 · Sep 30, 2025 −$1.01M
Net Income Q3 2025 · Jun 30, 2025 −$322K
Net Income Q3 2025 · Mar 31, 2025 −$429K
Net Income Q3 2025 · Sep 30, 2024 −$326K
Net Income Q3 2025 · Sep 30, 2024 −$1.12M
Net Income Q3 2025 · Jun 30, 2024 −$248K
Net Income Q3 2025 · Mar 31, 2024 −$550K
Operating Income Q3 2025 · Sep 30, 2025 −$251K
Operating Income Q3 2025 · Sep 30, 2025 −$991K
Operating Income Q3 2025 · Sep 30, 2024 −$319K
Operating Income Q3 2025 · Sep 30, 2024 −$1.12M